Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Vapor Annealing Controlled Crystal Growth and Photovoltaic Performance of Bismuth Triiodide Embedded in Mesostructured Configurations.

Kulkarni A, Singh T, Jena AK, Pinpithak P, Ikegami M, Miyasaka T.

ACS Appl Mater Interfaces. 2018 Mar 21;10(11):9547-9554. doi: 10.1021/acsami.8b00430. Epub 2018 Mar 9.

PMID:
29510034
2.

Three-dimensional mesostructures as high-temperature growth templates, electronic cellular scaffolds, and self-propelled microrobots.

Yan Z, Han M, Shi Y, Badea A, Yang Y, Kulkarni A, Hanson E, Kandel ME, Wen X, Zhang F, Luo Y, Lin Q, Zhang H, Guo X, Huang Y, Nan K, Jia S, Oraham AW, Mevis MB, Lim J, Guo X, Gao M, Ryu W, Yu KJ, Nicolau BG, Petronico A, Rubakhin SS, Lou J, Ajayan PM, Thornton K, Popescu G, Fang D, Sweedler JV, Braun PV, Zhang H, Nuzzo RG, Huang Y, Zhang Y, Rogers JA.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9455-E9464. doi: 10.1073/pnas.1713805114. Epub 2017 Oct 25.

3.

A microfluidic platform for drug screening in a 3D cancer microenvironment.

Pandya HJ, Dhingra K, Prabhakar D, Chandrasekar V, Natarajan SK, Vasan AS, Kulkarni A, Shafiee H.

Biosens Bioelectron. 2017 Aug 15;94:632-642. doi: 10.1016/j.bios.2017.03.054. Epub 2017 Mar 27.

4.

Poly(4-Vinylpyridine)-Based Interfacial Passivation to Enhance Voltage and Moisture Stability of Lead Halide Perovskite Solar Cells.

Chaudhary B, Kulkarni A, Jena AK, Ikegami M, Udagawa Y, Kunugita H, Ema K, Miyasaka T.

ChemSusChem. 2017 Jun 9;10(11):2473-2479. doi: 10.1002/cssc.201700271. Epub 2017 May 2.

PMID:
28371487
5.

High-Operating-Temperature Direct Ink Writing of Mesoscale Eutectic Architectures.

Boley JW, Chaudhary K, Ober TJ, Khorasaninejad M, Chen WT, Hanson E, Kulkarni A, Oh J, Kim J, Aagesen LK, Zhu AY, Capasso F, Thornton K, Braun PV, Lewis JA.

Adv Mater. 2017 Feb;29(7). doi: 10.1002/adma.201604778. Epub 2016 Dec 15.

PMID:
27976424
6.

Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy.

Kulkarni A, Natarajan SK, Chandrasekar V, Pandey PR, Sengupta S.

ACS Nano. 2016 Sep 29. [Epub ahead of print]

PMID:
27656909
7.

Algorithm for Designing Nanoscale Supramolecular Therapeutics with Increased Anticancer Efficacy.

Kulkarni A, Pandey P, Rao P, Mahmoud A, Goldman A, Sabbisetti V, Parcha S, Natarajan SK, Chandrasekar V, Dinulescu D, Roy S, Sengupta S.

ACS Nano. 2016 Sep 27;10(9):8154-68. doi: 10.1021/acsnano.6b00241. Epub 2016 Jul 29.

PMID:
27452234
8.

Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer.

Goldman A, Kulkarni A, Kohandel M, Pandey P, Rao P, Natarajan SK, Sabbisetti V, Sengupta S.

ACS Nano. 2016 Jun 28;10(6):5823-34. doi: 10.1021/acsnano.6b00320. Epub 2016 Jun 13.

PMID:
27257911
9.

Effect of Electron Transporting Layer on Bismuth-Based Lead-Free Perovskite (CH3NH3)3 Bi2I9 for Photovoltaic Applications.

Singh T, Kulkarni A, Ikegami M, Miyasaka T.

ACS Appl Mater Interfaces. 2016 Jun 15;8(23):14542-7. doi: 10.1021/acsami.6b02843. Epub 2016 Jun 2.

PMID:
27225529
10.

Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer.

Kulkarni AA, Vijaykumar VE, Natarajan SK, Sengupta S, Sabbisetti VS.

Nanomedicine. 2016 Oct;12(7):1853-1861. doi: 10.1016/j.nano.2016.04.002. Epub 2016 Apr 12.

PMID:
27084552
11.

Reporter nanoparticle that monitors its anticancer efficacy in real time.

Kulkarni A, Rao P, Natarajan S, Goldman A, Sabbisetti VS, Khater Y, Korimerla N, Chandrasekar V, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2104-13. doi: 10.1073/pnas.1603455113. Epub 2016 Mar 29.

12.

Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype.

Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, Gadish O, Sabbisetti V, Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, R Edelman E, Sengupta S.

Nat Commun. 2015 Dec 16;6:8671. doi: 10.1038/ncomms9671.

13.

Amphiphilic beads as depots for sustained drug release integrated into fibrillar scaffolds.

Gaharwar AK, Mihaila SM, Kulkarni AA, Patel A, Di Luca A, Reis RL, Gomes ME, van Blitterswijk C, Moroni L, Khademhosseini A.

J Control Release. 2014 Aug 10;187:66-73. doi: 10.1016/j.jconrel.2014.04.035. Epub 2014 Apr 29.

14.

Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy.

Pandey A, Kulkarni A, Roy B, Goldman A, Sarangi S, Sengupta P, Phipps C, Kopparam J, Oh M, Basu S, Kohandel M, Sengupta S.

Cancer Res. 2014 Feb 1;74(3):675-685. doi: 10.1158/0008-5472.CAN-12-3783. Epub 2013 Oct 11.

15.

Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy.

Kulkarni AA, Roy B, Rao PS, Wyant GA, Mahmoud A, Ramachandran M, Sengupta P, Goldman A, Kotamraju VR, Basu S, Mashelkar RA, Ruoslahti E, Dinulescu DM, Sengupta S.

Cancer Res. 2013 Dec 1;73(23):6987-97. doi: 10.1158/0008-5472.CAN-12-4477. Epub 2013 Oct 11.

16.

Design principles for clinical efficacy of cancer nanomedicine: a look into the basics.

Sengupta S, Kulkarni A.

ACS Nano. 2013 Apr 23;7(4):2878-82. doi: 10.1021/nn4015399.

17.

Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.

Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11294-9. doi: 10.1073/pnas.1203129109. Epub 2012 Jun 25.

18.

Carbohydrate-based label-free detection of Escherichia coli ORN 178 using electrochemical impedance spectroscopy.

Guo X, Kulkarni A, Doepke A, Halsall HB, Iyer S, Heineman WR.

Anal Chem. 2012 Jan 3;84(1):241-6. doi: 10.1021/ac202419u. Epub 2011 Dec 1.

PMID:
22035288
19.

Detection of carbohydrate binding proteins using magnetic relaxation switches.

Kulkarni AA, Weiss AA, Iyer SS.

Anal Chem. 2010 Sep 1;82(17):7430-5. doi: 10.1021/ac101579m.

PMID:
20684523
20.

Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.

Kulkarni AA, Fuller C, Korman H, Weiss AA, Iyer SS.

Bioconjug Chem. 2010 Aug 18;21(8):1486-93. doi: 10.1021/bc100095w.

Supplemental Content

Loading ...
Support Center